590 related articles for article (PubMed ID: 31115146)
1. Transcatheter aortic valve implantation in severe calcified annulus using the Lotus valve system: Increased incidence of fatal major vascular complications.
Conzelmann LO; Würth A; Balthasar V; Neuber C; Tzamalis P; Gonska BD; Schmitt C; Mehlhorn U; Schymik G
Catheter Cardiovasc Interv; 2020 Jan; 95(1):E21-E29. PubMed ID: 31115146
[TBL] [Abstract][Full Text] [Related]
2. Impact of severe left ventricular outflow tract calcification on device failure and short-term mortality in patients undergoing TAVI.
Jochheim D; Deseive S; Gschwendtner S; Bischoff B; Jochheim S; Hausleiter S; Zadrozny M; Baquet M; Tesche C; Massberg S; Mehilli J; Hausleiter J
J Cardiovasc Comput Tomogr; 2020; 14(1):36-41. PubMed ID: 31327744
[TBL] [Abstract][Full Text] [Related]
3. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve.
Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G
J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408
[TBL] [Abstract][Full Text] [Related]
4. Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
Montone RA; Testa L; Fraccaro C; Montorfano M; Castriota F; Nerla R; Angelillis M; Tusa M; Giannini F; Garatti A; Tarantini G; Petronio AS; Brambilla N; Bedogni F
Catheter Cardiovasc Interv; 2017 Dec; 90(7):1206-1211. PubMed ID: 28145039
[TBL] [Abstract][Full Text] [Related]
5. Computed tomography predictors of mortality, stroke and conduction disturbances in women undergoing TAVR: A sub-analysis of the WIN-TAVI registry.
Spaziano M; Chieffo A; Watanabe Y; Chandrasekhar J; Sartori S; Lefèvre T; Petronio AS; Presbitero P; Tchetche D; Iadanza A; Van Mieghem NM; Mehilli J; Mehran R; Morice MC;
J Cardiovasc Comput Tomogr; 2018; 12(4):338-343. PubMed ID: 29735255
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience.
Giannini F; Latib A; Montorfano M; Ruparelia N; Romano V; Longoni M; Ferri L; Jabbour R; Mangieri A; Regazzoli D; Ancona M; Buzzatti N; Azzalini L; Tanaka A; Agricola E; Chieffo A; Alfieri O; Colombo A
Catheter Cardiovasc Interv; 2018 Apr; 91(5):966-974. PubMed ID: 28941127
[TBL] [Abstract][Full Text] [Related]
7. Clinical and hemodynamic results after direct transcatheter aortic valve replacement versus pre-implantation balloon aortic valvuloplasty: A case-matched analysis.
Ferrera C; Nombela-Franco L; Garcia E; Jimenez-Quevedo P; Biagioni C; Gonzalo N; Nuñez-Gil I; Viana-Tejedor A; Salinas P; Alberto de Agustin J; Almeria C; Islas F; Perez de Isla L; Fernandez-Perez C; Escaned J; Fernández-Ortiz A; Macaya C
Catheter Cardiovasc Interv; 2017 Nov; 90(5):809-816. PubMed ID: 27515377
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Post-Dilatation on Outcomes in the PARTNER 2 SAPIEN 3 Registry.
Hahn RT; Pibarot P; Leipsic J; Blanke P; Douglas PS; Weissman NJ; Kapadia S; Thourani VH; Herrmann HC; Nazif T; McAndrew T; Webb JG; Leon MB; Kodali S
JACC Cardiovasc Interv; 2018 Sep; 11(17):1710-1718. PubMed ID: 30121276
[TBL] [Abstract][Full Text] [Related]
9. Impact of device landing zone calcification patterns on paravalvular regurgitation after transcatheter aortic valve replacement with different next-generation devices.
Mauri V; Frohn T; Deuschl F; Mohemed K; Kuhr K; Reimann A; Körber MI; Schofer N; Adam M; Friedrichs K; Kuhn EW; Scholtz S; Rudolph V; Wahlers TCW; Baldus S; Mader N; Schäfer U; Rudolph TK
Open Heart; 2020 May; 7(1):. PubMed ID: 32393655
[TBL] [Abstract][Full Text] [Related]
10. Predictability and Outcome of Vascular Complications after Transfemoral Transcatheter Aortic Valve Implantation.
Uguz E; Gokcimen M; Ali S; Alsancak Y; Bastug S; Ahmet Kasapkara H; Canyigit M; Hıdıroglu M; Sener E
J Heart Valve Dis; 2016 Mar; 25(2):173-181. PubMed ID: 27989061
[TBL] [Abstract][Full Text] [Related]
11. The ACURATE neo Transcatheter Heart Valve: A Comprehensive Analysis of Predictors of Procedural Outcome.
Kim WK; Möllmann H; Liebetrau C; Renker M; Rolf A; Simon P; Van Linden A; Arsalan M; Doss M; Hamm CW; Walther T
JACC Cardiovasc Interv; 2018 Sep; 11(17):1721-1729. PubMed ID: 29803694
[TBL] [Abstract][Full Text] [Related]
12. Procedural and thirty-day outcomes following transfemoral implantation of the fully repositionable and retrievable Lotus valve without routine pre-dilatation in a consecutive patient cohort: a single-center experience.
Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
Cardiovasc Revasc Med; 2018; 19(1 Pt B):78-82. PubMed ID: 29137967
[TBL] [Abstract][Full Text] [Related]
13. A feasibility study of transaxillary TAVI with the lotus valve.
Doshi SN; George S; Kwok CS; Mechery A; Mamas M; Ludman PF; Townend JN; Bhabra M
Catheter Cardiovasc Interv; 2018 Sep; 92(3):542-549. PubMed ID: 29130619
[TBL] [Abstract][Full Text] [Related]
14. VitaFlow™ transcatheter valve system in the treatment of severe aortic stenosis: One-year results of a multicenter study.
Zhou D; Pan W; Wang J; Wu Y; Chen M; Modine T; Mylotte D; Piazza N; Ge J
Catheter Cardiovasc Interv; 2020 Feb; 95(2):332-338. PubMed ID: 31020788
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Aortic Stenosis With a Self-Expanding, Resheathable Transcatheter Valve: One-Year Results of the International Multicenter Portico Transcatheter Aortic Valve Implantation System Study.
Linke A; Holzhey D; Möllmann H; Manoharan G; Schäfer U; Frerker C; Worthley SG; van Boven AJ; Redwood S; Kovac J; Butter C; Søndergaard L; Lauten A; Schymik G; Walther T
Circ Cardiovasc Interv; 2018 Feb; 11(2):e005206. PubMed ID: 29444998
[TBL] [Abstract][Full Text] [Related]
16. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
Jatene T; Castro-Filho A; Meneguz-Moreno RA; Siqueira DA; Abizaid AAC; Ramos AIO; Arrais M; Le Bihan DCS; Barretto RBM; Moreira AC; Sousa AGMR; Eduardo Sousa J
Catheter Cardiovasc Interv; 2017 Jul; 90(1):139-146. PubMed ID: 28029207
[TBL] [Abstract][Full Text] [Related]
17. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement.
Seeger J; Gonska B; Rottbauer W; Wöhrle J
Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290
[TBL] [Abstract][Full Text] [Related]
18. Use of a Repositionable and Fully Retrievable Aortic Valve in Routine Clinical Practice: The RESPOND Study and RESPOND Extension Cohort.
Van Mieghem NM; Wöhrle J; Hildick-Smith D; Bleiziffer S; Blackman DJ; Abdel-Wahab M; Gerckens U; Linke A; Ince H; Wenaweser P; Allocco DJ; Meredith IT; Falk V
JACC Cardiovasc Interv; 2019 Jan; 12(1):38-49. PubMed ID: 30621976
[TBL] [Abstract][Full Text] [Related]
19. Severe aortic stenosis with low aortic valve calcification: characteristics and outcome following transcatheter aortic valve implantation.
Abramowitz Y; Jilaihawi H; Pibarot P; Chakravarty T; Kashif M; Kazuno Y; Maeno Y; Kawamori H; Mangat G; Friedman J; Cheng W; Makkar RR
Eur Heart J Cardiovasc Imaging; 2017 Jun; 18(6):639-647. PubMed ID: 28369223
[TBL] [Abstract][Full Text] [Related]
20. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
